Recruiting studies: Biologic Inadequate

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Phase 3 · 16 location(s) · Takeda · NCT07286058 Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severel
Phase 3 · 85 location(s) · AbbVie · NCT06332534 Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease
Phase 4 · 1 location(s) · Erasmus Medical Center · NCT05552287 Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate
Phase N/A · 1 location(s) · Pfizer · NCT06899204 A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in
Phase 3 · 150 location(s) · Sanofi · NCT06241118

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.